Clinicopathological significance and potential drug target of RUNX3 in breast cancer

References

• Siegel R Naishadham D Jemal A Cancer statistics, 2013 CA Cancer J Clin 2013 63 11 30 23335087
   PubMed Web of Science ®Google Scholar
• Redig AJ McAllister SS Breast cancer as a systemic disease: a view of metastasis J Intern Med 2013 274 113 126 23844915
   PubMed Web of Science ®Google Scholar
• Coleman RE Gregory W Marshall H Wilson C Holen I The metastatic microenvironment of breast cancer: clinical implications Breast 2013 22 Suppl 2 S50 S56 24074793
   PubMed Web of Science ®Google Scholar
• Ozaki T Nakagawara A Nagase H RUNX Family participates in the regulation of p53-dependent DNA damage response Int J Genomics 2013 2013 271347 24078903
   PubMed Web of Science ®Google Scholar
• Ito Y RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes Adv Cancer Res 2008 99 33 76 18037406
   PubMed Web of Science ®Google Scholar
• Blyth K Cameron ER Neil JC The RUNX genes: gain or loss of function in cancer Nat Rev Cancer 2005 5 376 387 15864279
   PubMed Web of Science ®Google Scholar
• Subramaniam MM Chan JY Yeoh KG Quek T Ito K Salto-Tellez M Molecular pathology of RUNX3 in human carcinogenesis Biochim Biophys Acta 2009 1796 315 331 19682550
   PubMed Web of Science ®Google Scholar
• Lund AH van Lohuizen M RUNX: a trilogy of cancer genes Cancer Cell 2002 1 213 215 12086855
   PubMed Web of Science ®Google Scholar
• Levanon D Negreanu V Bernstein Y Bar-Am I Avivi L Groner Y AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization Genomics 1994 23 425 432 7835892
   PubMed Web of Science ®Google Scholar
• Chi XZ Kim J Lee YH Runt-related transcription factor RUNX3 is a target of MDM2-mediated ubiquitination Cancer Res 2009 69 8111 8119 19808967
   PubMed Web of Science ®Google Scholar
• Shiraha H Nishina S Yamamoto K Loss of runt-related transcription factor 3 causes development and progression of hepatocellular carcinoma J Cell Biochem 2011 112 745 749 21328447
   PubMed Web of Science ®Google Scholar
• Li QL Ito K Sakakura C Causal relationship between the loss of RUNX3 expression and gastric cancer Cell 2002 109 113 124 11955451
   PubMed Web of Science ®Google Scholar
• Chi XZ Yang JO Lee KY RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD Mol Cell Biol 2005 25 8097 8107 16135801
   PubMed Web of Science ®Google Scholar
• Wei D Gong W Oh SC Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis Cancer Res 2005 65 4809 4816 15930301
   PubMed Web of Science ®Google Scholar
• Chen LF Tumor suppressor function of RUNX3 in breast cancer J Cell Biochem 2012 113 1470 1477 22275124
   PubMed Web of Science ®Google Scholar
• Tanaka S Shiraha H Nakanishi Y Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma Int J Cancer 2012 131 2537 2546 22488108
   PubMed Web of Science ®Google Scholar
• Li J Jiang X Loss of runt-related transcription factor 3 expression associated with human hepatocellular carcinoma progression and prognosis Asian Pac J Cancer Prev 2011 12 2285 2290 22296371
   PubMedGoogle Scholar
• Voon DC Wang H Koo JK Runx3 protects gastric epithelial cells against epithelial-mesenchymal transition-induced cellular plasticity and tumorigenicity Stem Cells 2012 30 2088 2099 22899304
   PubMed Web of Science ®Google Scholar
• Voon DC Wang H Koo JK EMT-induced stemness and tumorigenicity are fueled by the EGFR/Ras pathway PloS One 2013 8 e70427 23950932
   PubMed Web of Science ®Google Scholar
• Liu Z Chen L Zhang X RUNX3 regulates vimentin expression via miR-30a during epithelial-mesenchymal transition in gastric cancer cells J Cell Mol Med 2014 18 610 623 24447545
   PubMed Web of Science ®Google Scholar
• Subramaniam MM Chan JY Omar MF Lack of RUNX3 inactivation in columnar cell lesions of breast Histopathology 2010 57 555 563 20955380
   PubMed Web of Science ®Google Scholar
• Huang B Qu Z Ong CW RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor alpha Oncogene 2012 31 527 534 21706051
   PubMed Web of Science ®Google Scholar
• McShane LM Altman DG Sauerbrei W Taube SE Gion M Clark GM Reporting recommendations for tumor marker prognostic studies (REMARK) J Natl Cancer Inst 2005 97 1180 1184 16106022
   PubMed Web of Science ®Google Scholar
• Steels E Paesmans M Berghmans T Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis Eur Respir J 2001 18 705 719 11716177
   PubMed Web of Science ®Google Scholar
• Gyorffy B Lanczky A Eklund AC An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients Breast Cancer Res Treat 2010 123 725 731 20020197
   PubMed Web of Science ®Google Scholar
• DerSimonian R Laird N Meta-analysis in clinical trials Control Clin Trials 1986 7 177 188 3802833
   PubMed Web of Science ®Google Scholar
• Higgins JP Thompson SG Deeks JJ Altman DG Measuring inconsistency in meta-analyses BMJ 2003 327 557 560 12958120
   PubMed Web of Science ®Google Scholar
• DerSimonian R Meta-analysis in the design and monitoring of clinical trials Stat Med 1996 15 1237 1248 discussion 49–52 8817798
   PubMed Web of Science ®Google Scholar
• Egger M Davey Smith G Schneider M Minder C Bias in meta-analysis detected by a simple, graphical test BMJ 1997 315 629 634 9310563
   PubMed Web of Science ®Google Scholar
• Chuang LS Ito Y RUNX3 is multifunctional in carcinogenesis of multiple solid tumors Oncogene 2010 29 2605 2615 20348954
   PubMed Web of Science ®Google Scholar
• Lee JH Pyon JK Kim DW Expression of RUNX3 in skin cancers Clin Exp Dermatol 2011 36 769 774 21623876
   PubMed Web of Science ®Google Scholar
• Lee JM Shin JO Cho KW Runx3 is a crucial regulator of alveolar differentiation and lung tumorigenesis in mice Differentiation 2011 81 261 268 21367515
   PubMed Web of Science ®Google Scholar
• Lee YM Control of RUNX3 by histone methyltransferases J Cell Biochem 2011 112 394 400 21268059
   PubMed Web of Science ®Google Scholar
• Levanon D Brenner O Otto F Groner Y Runx3 knockouts and stomach cancer EMBO Rep 2003 4 560 564 12776174
   PubMed Web of Science ®Google Scholar
• Lee YS Lee JW Jang JW Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma Cancer Cell 2013 24 603 616 24229708
   PubMed Web of Science ®Google Scholar
• Araki K Osaki M Nagahama Y Expression of RUNX3 protein in human lung adenocarcinoma: implications for tumor progression and prognosis Cancer Sci 2005 96 227 231 15819721
   PubMed Web of Science ®Google Scholar
• Subramaniam MM Chan JY Soong R RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression Breast Cancer Res Treat 2009 113 113 121 18256927
   PubMed Web of Science ®Google Scholar
• Hwang KT Han W Bae JY Downregulation of the RUNX3 gene by promoter hypermethylation and hemizygous deletion in breast cancer J Korean Med Sci 2007 22 Suppl S24 S31 17923751
   PubMed Web of Science ®Google Scholar
• Mu WP Wang J Niu Q Shi N Lian HF Clinical significance and association of RUNX3 hypermethylation frequency with colorectal cancer: a meta-analysis Onco Targets Ther 2014 7 1237 1245 25053885
   PubMed Web of Science ®Google Scholar
• Yang Y Ye Z Zou Z Xiao G Luo G Yang H Clinicopathological significance of RUNX3 gene hypermethylation in hepatocellular carcinoma Tumour Biol 2014 19 19
   Google Scholar
• Kang HF Dai ZJ Bai HP RUNX3 gene promoter demethylation by 5-Aza-CdR induces apoptosis in breast cancer MCF-7 cell line Onco Targets Ther 2013 6 411 417 23723708
   PubMed Web of Science ®Google Scholar
• Lau QC Raja E Salto-Tellez M RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer Cancer Res 2006 66 6512 6520 16818622
   PubMed Web of Science ®Google Scholar
• Chen W Salto-Tellez M Palanisamy N Targets of genome copy number reduction in primary breast cancers identified by integrative genomics Genes Chromosomes Cancer 2007 46 288 301 17171680
   PubMed Web of Science ®Google Scholar
• Delpu Y Cordelier P Cho WC Torrisani J DNA methylation and cancer diagnosis Int J Mol Sci 2013 14 15029 15058 23873296
   PubMed Web of Science ®Google Scholar
• Ma X Wang YW Zhang MQ Gazdar AF DNA methylation data analysis and its application to cancer research Epigenomics 2013 5 301 316 23750645
   PubMed Web of Science ®Google Scholar
• Lee SH Bae SC Kim KW Lee YM RUNX3 inhibits hypoxia-inducible factor-1α protein stability by interacting with prolyl hydroxylases in gastric cancer cells Oncogene 2014 33 11 1458 1467 23542169
   PubMed Web of Science ®Google Scholar
• Yamada C Ozaki T Ando K RUNX3 modulates DNA damage-mediated phosphorylation of tumor suppressor p53 at Ser-15 and acts as a co-activator for p53 J Biol Chem 2010 285 16693 16703 20353948
   PubMed Web of Science ®Google Scholar
• Li DX Wu H Gao JZ Fang ZX Relationship between methylation status of Runx3 gene promoter and Runx3 protein expression in patients with breast cancer China Maternal and Child Health 2013 28 3650 3653
   Google Scholar
• Park SY Kwon HJ Choi Y Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes Mod Pathol 2012 25 185 196 22037257
   PubMed Web of Science ®Google Scholar
• Qiao L Yang ZY Liu W Clinical significance of detecting plasma Runx3 gene promoter methylation in early diagnosis breast cancer Mod Lab Med 2012 27 35 37
   Google Scholar
• Park SY Kwon HJ Lee HE Promoter CpG island hypermethylation during breast cancer progression Virchows Arch 2011 458 73 84 21120523
   PubMed Web of Science ®Google Scholar
• Du JR Lou G Jiang Y Relationship between the methylation of RUNX3 promoter and the clinical pathological characters and prognostic factors of breast invasive ductal carcinoma Journal of Harbin Medical University 2008 1 019
   Google Scholar
• Tian SW Jia SC Chen J Analysis of the status of Runx3 gene promoter methylation in breast cancer and its relationship with pathological features Chin J Breast Dis 2010 4 50 53
   Google Scholar
• Jiang Y Tong D Lou G Zhang Y Geng J Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines Pathobiology 2008 75 244 251 18580070
   PubMed Web of Science ®Google Scholar
• Suzuki M Shigematsu H Shames DS DNA methylation-associated inactivation of TGFbeta-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancers Br J Cancer 2005 93 1029 1037 16234815
   PubMed Web of Science ®Google Scholar